The Nuclear Regulatory Commission has made public an unclassified version of its annual report to Congress on the results of its security inspection activities in 2022.

The Nuclear Regulatory Commission has issued its final safety evaluation report (SER) related to the operating license application for SHINE Technologies' large-scale medical isotope production facility, known as The Chrysalis, in Janesville, Wis. The SER documents the results of NRC staff’s technical and safety review of SHINE’s application. SHINE announced the NRC’s decision on February 27.

A record of decision concerning the proposed issuance of the operating license will be published by the NRC at a future date.

The staff of the Nuclear Regulatory Commission recently released a draft white paper outlining strategies for streamlining microreactor licensing. The paper is to be used to facilitate discussion at an upcoming advanced reactor stakeholder public meeting.

“This paper,” the document emphasizes, “has not been subject to NRC management and legal reviews and approvals, and its contents are subject to change and should not be interpreted as official agency positions.”